Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-07

FDA Approved: LIDOCAINE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lidocaine patch 5% (Lidocaine Patch) from Endo USA, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine patch 5% (Lidocaine)

Snippet

SUPPL AP for LIDOCAINE (LIDOCAINE)